BioTuesdays

Category - News

TransEnterix
Markets

BTIG cuts TransEnterix to neutral on rapid stock rise

BTIG downgraded TransEnterix (NASDAQ:TRXC) to “neutral” from “buy,” citing a tripling in the stock price, which has exceeded its price target of $3.50. The stock closed at $5.84 on June 27. “We continue to like the...

June 28, 2018
Imagin Medical Logo
Markets

Imagin Medical uplists to OTCQB

The common shares of Imagin Medical (CSE:IME; OTC:IMEXF) were approved for uplisting from the Pink Open Market to the OTCQB Venture Market, with the same symbol, IMEXF, effective at the open on June 28, 2018. “Uplisting...

June 28, 2018
Zosano Logo
Markets

BTIG starts Zosano Pharma at buy; PT $19

BTIG launched coverage of Zosano Pharma (NASDAQ:ZSAN) with a “buy” rating and 12-month price target of $19. The stock closed at $3.80 on June 27. Zosano is focused on the development of therapeutics using its ADAM...

June 28, 2018
Aquinox Pharmaceuticals
Developments

Aquinox Pharma AQX-1125 fails Phase 3 trial

Aquinox Pharmaceuticals (NASDAQ:AQXP) announced that the Phase 3 LEADERSHIP 301 clinical trial, evaluating once-daily, oral rosiptor (AQX-1125) for the treatment of interstitial cystitis/bladder pain syndrome, failed to...

June 27, 2018
Palatin Technologies Logo
Markets

Ladenburg starts Palatin Technologies at buy; PT $3

Ladenburg Thalmann initiated coverage of Palatin Technologies (NYSE MKT:PTN) with a “buy” rating and $3 price target. The stock closed at $1.05 on June 26. Palatin’s lead asset, bremelanotide (BMT), is a melanocortin...

June 27, 2018
Tocagen Logo
Markets

Ladenburg starts Tocagen at buy; PT $20

Ladenburg Thalmann launched coverage of Tocagen (NASDAQ: TOCA) with a “buy” rating and $20 price target. The stock closed at $8.81 on June 26. TOCA is developing a novel viral gene therapy for cancer and has developed a...

June 27, 2018
AtriCure Logo
Markets

Analysts hike AtriCure PT after analyst day meeting

Analysts for Stifel and Canaccord Genuity raised their price targets for AtriCure (NASDAQ:ATRC) after an analyst day meeting highlighted the significant penetration opportunity in the atrial fibrillation (AF) market...

June 27, 2018
IntelGenx Logo
Markets

Maxim starts IntelGenx at buy; PT $3

Maxim Group initiated coverage of IntelGenx (OTCQX:IGXT; TSXV:IGX) with a “buy” rating and price target of $3. The stock closed at 78 cents on June 26. Analyst Jason McCarthy writes that the company’s VersaFilm is a...

June 27, 2018
Avenue Therapeutics Logo
Markets

HCW starts Avenue Therapeutics at buy; PT $11

H.C. Wainwright initiated coverage of Avenue Therapeutics (NASDAQ:ATXI) with a “buy” rating and price target of $11. The stock closed at $3.77 on June 25. Avenue Therapeutics is focused on the acute care hospital...

June 26, 2018